Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term efficacy of Daivobet Ointment in plaque psoriasis (Chinese multicenter, hybrid-virtual study)
ChiCTR2300072465Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of calcipotriol + betamethasone in plaque psoriasis (2 arms), sponsored by Xijing Hospital. Primary endpoint: Proportion of patients with PGA 0/1 at 26 weeks of treatment. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2300072465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072465.